<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00978848</url>
  </required_header>
  <id_info>
    <org_study_id>PRO8120077</org_study_id>
    <nct_id>NCT00978848</nct_id>
  </id_info>
  <brief_title>Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing</brief_title>
  <official_title>Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing: Meeting the Needs of an At-Risk Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Gen-Probe, Incorporated</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the prevalence and treatment rates of T. vaginalis,
      C. trachomatis, and N. gonorrhoeae in women seeking emergency contraception or urine
      pregnancy testing in the Magee-Womens Hospital outpatient clinic using a non-invasive urine
      STD test.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study has three primary objectives: 1) to determine the prevalence of T. vaginalis, C.
      trachomatis, and N. gonorrhoeae in women seeking emergency contraception or urine pregnancy
      testing - a population likely at increased risk of acquiring STDs; 2) to determine the rate
      of successful treatment in women diagnosed with STDs in this venue.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">305</enrollment>
  <condition>Trichomonas Vaginitis</condition>
  <condition>Chlamydia Trachomatis</condition>
  <condition>Neisseria Gonorrhoeae Infection</condition>
  <arm_group>
    <arm_group_label>Women seeking emergency contraception</arm_group_label>
    <description>Women seeking emergency contraception</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Women seeking urine pregnancy testing</arm_group_label>
    <description>Women seeking urine pregnancy testing</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Any left over urine may be frozen for future use on infections in women
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Females at least age 15 at time of enrollment who are presenting at Magee-Womens Hospital
        for emergency contraception or urine pregnancy testing
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females at least age 15 at time of enrollment who are presenting at Magee-Womens
             Hospital for emergency contraception or urine pregnancy testing.

          -  Ability to provide written informed consent.

        Exclusion Criteria:

          -  Diagnosis and/or treatment for an STD within 4 weeks of enrollment in the study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harold C Wiesenfeld, MD, CM</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Magee-Womens Hospital of UPMC</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2009</study_first_submitted>
  <study_first_submitted_qc>September 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2009</study_first_posted>
  <last_update_submitted>May 17, 2016</last_update_submitted>
  <last_update_submitted_qc>May 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Harold Wiesenfeld</investigator_full_name>
    <investigator_title>Director, Division of Gynecologic Specialties &amp; Division of Reproductive Infectious Diseases and Immunology</investigator_title>
  </responsible_party>
  <keyword>trichomonas</keyword>
  <keyword>chlamydia</keyword>
  <keyword>gonorrhea</keyword>
  <keyword>emergency contraception</keyword>
  <keyword>emergency contraception use</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Chlamydia Infections</mesh_term>
    <mesh_term>Sexually Transmitted Diseases</mesh_term>
    <mesh_term>Gonorrhea</mesh_term>
    <mesh_term>Vaginitis</mesh_term>
    <mesh_term>Trichomonas Infections</mesh_term>
    <mesh_term>Trichomonas Vaginitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

